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Objectives: to assess renal function in elderly patients undergoing contrast-enhanced computed 
tomography and identify the preventive measures of acute kidney injury in the period before 
and after the examination. Method: longitudinal cohort study conducted at the Federal 
University of São Paulo Hospital, from March 2011 to March 2013. All hospitalized elderly, of 
both sexes, aged 60 years and above, who performed the examination, were included (n=93). 
We collected sociodemographic data, data related to the examination and to the care provided, 
and creatinine values prior and post exam. Results: an alteration in renal function was observed 
in 51 patients (54%) with a statistically significant increase of creatinine values (p<0.04), and 
two patients (4.0%) required hemodialysis. Conclusion: There is an urgent need for protocols 
prior to and post contrast-enhanced examination in the elderly, and other studies to verify the 
prognosis of this population.
Descriptors: Acute Kidney Injury; Contrast Media; Aged; Nursing Care.
Acute kidney injury after contrast-enhanced
examination among elderly1
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Introduction
Acute Kidney Injury (AKI) is characterized most 
commonly by an increase of ≥25% in serum creatinine 
or an absolute increase of 0.5mg/dL above baseline(1). 
The main causes of AKI are: ischemia, nephrotoxicity 
due to antibiotics, heavy metals, organic solvents, 
poisons, chemicals, anesthetics, endogenous factors, 
glomerular and vascular diseases, nephritis, diuretics, 
non-steroidal anti-inflammatory medications and 
radiographic contrast(2-3). The activity exercised by 
the latter is the transient increase of renal blood 
flow, followed by its decrease. It is believed that 
contrast-induced vasoconstriction is the cause of 
renal ischemia, a major factor in the pathogenesis 
of nephrotoxicity(4).
The main signs and symptoms of AKI are: oliguria 
or anuria, weakness, apathy, loss of appetite, nausea, 
vomiting, Kussmaul breathing, pulmonary edema, 
peripheral edema, ascites, cardiac arrhythmias and 
coma. The treatment of AKI in general involves dialysis 
and nutritional and fluid therapy(5-6).
The use of contrast media in tests such as 
angiography, urography or computed tomography can 
trigger systemic hypersensitivity reactions, cardiac 
adverse reactions, vascular and renal adverse effects. 
The amount and nature of contrast used and preexisting 
risk factors determine the severity of side effects. 
Contrasts that have high osmolarity are demonstrably 
more nephrotoxic than those with low osmolarity(7). 
The main factors of preexisting risk for AKI are: renal 
failure, diabetes mellitus, heart failure, hypotension, 
dehydration, and the use of medications such as diuretics 
and non-steroidal anti-inflammatories(8).
CO2 is a type of contrast agent that can be used 
in exams, such as digital angiography, as it offers 
a reduced risk of toxicity, and is a safe alternative to 
iodine-based contrast(9). Barium sulfate, administered 
orally or rectally, is a contrast agent used in radiological 
examinations of the esophagus, stomach, intestines, 
colon and great vessels of the heart, that can trigger 
toxic reactions in the hours following its administration, 
such as: nausea, vomiting, diarrhea, abdominal pain, 
agitation, anxiety, weakness, fainting, sweating, 
tremors, muscle fibrillation, stiffness of the face and 
neck muscles, dyspnea, cardiac arrhythmia, paresthesia 
of upper and lower limbs, convulsions and coma crisis(10).
A study demonstrated that the use of non-ionic 
contrast-enhanced angiography did not reduce kidney 
damage in patients who already had impaired renal 
function after examination, when compared to the use 
of ionic contrasts(11). A meta-analysis that included 
twenty-two studies demonstrated a 13.6% incidence 
of AKI in patients ≥65 years of age(12). AKI is the third 
leading cause of kidney disease in hospitalized patients, 
and substantially increases the length of hospital stay, 
cost of care and intra-hospital mortality(13-14).
Contrast-induced nephropathy (CIN) is an increase 
of >25% in the baseline levels of serum creatinine. Some 
studies report that an increase of creatinine occurs within 
48 hours(6,13), and others between 48-72 hours(4,8,15) 
after the administration of the contrast agent.
The various contrast media differ in biochemical 
and physical aspects, and in regard to their properties 
related to efficacy. The chemical structure, viscosity, 
osmolality and ionicity are also considered. The non-
ionic compounds and the ones with low osmolarity were 
considered less nephrotoxic than the hyperosmolar 
ones(4,13). Yet another type of contrast is being 
developed, characterized by its nonionic dimers that give 
the molecule a high affinity with the aqueous medium, 
thereby decreasing the incidence of nephrotoxicity; such 
compounds are called isosmolar(4).
Renal lesions caused by the use of contrast 
are classified into acute tubular necrosis (ATN) 
and acute tubulointerstitial nephritis (ATIN)(6). The 
pathophysiology of ATN is multifactor and involves 
changes in renal hemodynamics and the renal 
tubules due to a biphasic response: interspersed 
vasodilation with vasoconstriction which decreases 
renal blood flow, causing renal ischemia(8,15). CIN is 
characterized by the damage of epithelial cells of the 
renal tubules causing decreased renal blood flow that 
leads to hypoxia in the renal medulla, and also by the 
appearance of granular cylinders, erythrocytes and 
inflammatory cells in the urine; ATIN can manifest in a 
milder form(6).
Examination of renal ultrasound shows that 
contrast-induced AKI leads to increased renal 
dimensions. In these cases, scintigraphy with gallium 
detects inflammatory cells. However, definitive diagnosis 
is established after renal biopsy(6). For the prevention of 
contrast-induced AKI, the use of diuretics is indicated, as 
well as that of vasodilators, hydration, pharmacological 
vasoconstrictors, and antioxidants inhibitors(8,16).
N-acetylcysteine is the most studied compound in 
the prevention of contrast-induced AKI. It inhibits the 
action of free radicals thereby protecting renal function. 
Prophylaxis is most effective when the medication is 
administered orally, 24 hours before the procedure(16). 
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A study published in Israel, in 2013, showed no 
benefit in the use of N-acetylcysteine to prevent 
contrast-induced AKI, but showed a significant 
association between the solution volumes 
administered for the prevention of contrast-induced 
nephropathy(17).
In elderly subjects, the anatomical and 
physiological changes in the kidneys, caused by the 
aging process of the kidney, constitutes an aggravating 
factor for kidney disease, increasing the susceptibility of 
renal dysfunction over the years(4-5). A study conducted 
in São Paulo, with 361 patients, showed that 35% of 
the elderly presented AKI due to nephrotoxic factors, 
with one of the predominant causes of nephrotoxicity 
in this group being the use of contrast for radiologic 
examinations. The physiology of the kidney in the 
elderly should be considered when contrast-enhanced 
exams are requested and performed, since an older 
individual presents more risks for complications when 
undergoing invasive procedures and with nephrotoxic 
medication use. Advanced prognosis of AKI in elderly 
patients is characterized by oliguria, the need for 
dialysis, presence of sepsis, and hospitalization in 
intensive care units(18).
Hydration, use of medications that reduce 
renal vasoconstriction and oxidative stress, the use 
of less nephrotoxic contrast, dose adjustment, and 
discontinuation of medications with nephrotoxic 
potential should be considered when contrast-enhanced 
examinations are requested, especially when it comes 
to the elderly(19).
We understand that knowing the frequency of 
alterations in the renal function of the elderly after 
contrast-enhanced examinations can target and support 
the creation and implementation of protocols for AKI 
prevention among the elderly population. 
Facing this scenario, the study objectives were: to 
assess the impact of changes in renal function in elderly 
inpatients undergoing computed tomography using 
contrast medium, and, to identify preventive measures 
of acute kidney injury in the periods before and after the 
contrast-enhanced CT examination.
Methods
Ethical Considerations
The study was approved by the Board of Ethics in 
Research of the Federal University of São Paulo, under 
the aforementioned protocol (CEP 1270/09).
Design, study site and study period
Longitudinal cohort design conducted at the 
São Paulo Hospital, Federal University of São Paulo –
UNIFESP, from March 2011 to March 2013.
Population
All elderly hospitalized during the study period and 
who underwent computerized tomography were included 
in the study. The sample consisted of 93 elderly patients 
of both sexes, with a minimum age of 60 years.
Study protocol 
A daily search was made in the CT sector records of 
all seniors who were examined using contrast media, in 
addition to the identification of the investigated region 
in the CT exam, and the type and volume of contrast 
used. Following this survey, the medical records of 
these patients were evaluated at the hospital for three 
days prior to the computed tomography, in order to 
verify the care provided; and for three days after the 
CT scan, also to check the care provided and changes 
in creatinine values. The following data were collected: 
sociodemographic and morbidity characteristics, 
indication for examination, exam type, contrast 
agent and dose used, type of preparation before the 
examination, care provided after the examination, and 
serum creatinine values before and after the computed 
tomography scan.
Results
Ninety-three elderly who underwent a contrast-
enhanced CT scan were studied, with 58 (62.4%) who 
were male and 35 (37.6%) who were female. The mean 
age of patients was 70.3 years (60-90 years).
Most of the CT scans were done to examine the 
thoracic region, followed by abdominal, head, pelvis 
and other locations. A total of 121 CT examinations 
were performed, with a mean of 1.3 exams per patient. 
No standardization was identified in regard to the 
type of records completed, and the recorded notes 
varied according to the technician responsible for the 
examination. Among the 93 records analyzed, 18 
(19.4%) did not present any information on the type 
and dose of contrast used, only in 48.4% of the records 
were notes found on the volume administered without 
the contrast agent identified, and in only 30 (32.2%) 
were data found on the volume and type of contrast 
used for the examination (Table 1).
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Characteristics of the elderly
Sex
Male 58 (62.4)
Female 35 (37.6)
Age 70.3 (60-90)
CT
Thoracic Region 47 (38.8)
Abdominal 35 (28.9)
Head 18 (14.8)
Pelvis 10 (8.3)
Other 11 (9.1)
Total number of CT scan* 121
Mean number of CT scans per patient 1.3
Records on the use of contrast media
No data 18 (19.4)
Data on the dose used 45 (48.4)
Data on the dose and type used 30 (32.2)
Types of contrast
Ionic 4 (4.2)
Non-ionic 26 (28.0)
Table 1 - Characteristics of the elderly and of the 
contrast-enhanced CT scans, São Paulo, SP, Brazil, 2013
*Some patients had more than one CT
Values in numbers (%) and mean value (variation)
During the study, it was found that 33 (35.5%) 
patients who underwent contrast-enhanced computed 
tomography did not receive prophylactic measures 
related to the possible prevention of AKI, while 60 
(64.5%) received some type of preparation. Among 
patients who received some sort of preparation, 46 
(49.5%) were intravenously hydrated with normal 
saline (0.9% NS), 14 patients (15.0%) had 0.9% NS 
and N-acetylcysteine, and one patient received 0.9% NS 
followed by increased fluid intake. The mean time for 
preparation prior to the exam was 26.9 hours.
In the period after the contrast-enhanced exam, 
49 (52.7%) patients did not receive any preventive 
measure, while 44 (47.3%) received some sort of care 
after the examination. Among patients who received 
care, 35 (37.63%) were hydrated with 0.9% NS, 7 
(7.52%) used 0.9% NS and N-acetylcysteine, and two 
(3.9%) required hemodialysis after the exam, due to 
considerable elevation of serum creatinine. The mean 
time required for care provision after the examination 
was 57.04 hours. 
Among 24 (25.8%) elderly who underwent CT with 
contrast, serum creatinine was not measured, and in 69 
(74.2%) patients serum creatinine values were found in 
the records before the exam. The data analysis allowed 
the observation that the median creatinine value before 
the examination was 1.00mg/dL, ranging from 0.38 mg/
dL to 2.05mg/dL.
The study also showed that the serum creatinine 
was not requested after the exam for 42 (45.16%) 
patients. The record control of serum creatinine values 
before and after the exam was observed in only 51 
individuals. The median creatinine after the exam 
contrast was 1.04mg/dL with changes that ranged 
from 0.41mg/dL to 6.00mg/dL, featuring considerable 
elevation of serum creatinine (Table 2). Importantly, 
two (4%) patients required hemodialysis. The Student’s 
t-test between values of creatinine before and after CT 
examination enabled a statistically significant finding 
of p≤0.04, showing that the creatinine values in these 
patients were above normal values.
Table 2 - Types of preparations for patients who 
underwent CT scans, and serum creatinine levels before 
and after the CT exam, São Paulo, SP, Brazil, 2013
*p value <0.04
Values are expressed as n (%), mean, median (variation), and creatinine 
unit of measure in mg/dL
Preparations types and serum creatinin levels
Preparation before CT
No 33 (35.5)
Yes 60 (64.5)
Hydration with 0.9% NS 46 (49.5)
Hydration with 0.9% NS and N-acetylcysteine 14 (15.0)
Preparation hours 26.9
Care after CT
No 49 (52.7)
Yes 44 (47.3)
0.9% NS after CT 35 (37.6)
0.9% NS and N-acetylcysteine after CT 7 (7.5)
Hemodyalisis after CT 2 (4.0)
Care hours after CT 57.0
Creatinine values before CT
No 24 (25.8)
Yes 69 (74.2)
Median creatinine value before CT 1.0 (0.38-2.05)
Creatinine value after CT
No 42 (45.2)
Yes 51 (54.8)
Median creatinine value after CT 1.04 (0.41-6.0)*
Discussion
The increase in life expectancy in Brazil caused a 
higher incidence and prevalence of diseases such as 
diabetes, hypertension, cardiovascular disease, stroke 
and senile dementia, often culminating in hospitalizations 
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and causing an increased need for examinations, 
including those using contrast media. Males present 
a greater tendency for developing cerebrovascular 
disease, acute myocardial infarction and systemic 
hypertension(20). Aggravating factors that increase 
this statistic include habits such as: smoking, stress, 
inactivity, intake of products with high cholesterol, as 
well as a precarious economic status(21). In the present 
study we observed concordance with the findings of the 
abovementioned work, given that 62.4% of the elderly 
who underwent computerized tomography with contrast 
were male.
According to the protocol that aims to reduce the 
rate of contrast-induced nephropathy, patients who 
undergo contrast examinations should also have serum 
creatinine level measurement before and two days after 
the procedure, in addition to the calculation of estimated 
glomerular filtration rate, use of low-osmolar contrast 
in case of underlying disease that predisposes renal 
disorder due to the use of contrast; administration of 
doses <5 ml/kg/serum creatinine (mg/dl); hydration 
with 0.9% NS solution of 1 mL/kg/h for 12 hours 
before and after the examination; oral hydration of 
≥2 liters before the exam if the procedure is in outpatient 
services, and cessation of nephrotoxic medications or 
medication requiring renal excretion(19).
In the present study it was revealed that the 
institution where the study was conducted followed no 
standardized protocol for prevention of renal damage, 
whereas 35.5% of patients who had CT with contrast 
were not prepared for the exam, and 52.7% of the 
sampled population did not receive adequate care after 
the procedure. There was also no standardization in 
relation to the exam records.
Records relating to the contrast are extremely 
important, since several studies that evaluated different 
types and doses of contrasts demonstrated that their 
toxicity depended on the degree of osmolarity presented 
by the agents, i.e., osmolar contrasts are considered 
less nephrotoxic, as well as non-ionic ones(19). In this 
study, the number of records that had notes on the 
type of contrast used in performing the CT examination 
was 32.2%, and the remaining 67.8% of the analyzed 
records did not contain records on the type of contrast 
used. The lack of information may reflect negatively 
on the decision of possible attitudes related to the 
prevention of renal damage.
In addition to documenting the type of contrast 
being of great relevance, studies correlate the amount of 
contrast administered to the risk of AKI. Other authors 
also believe that even small dosages could induce renal 
failure(22). In this study, 19.4% of the analyzed records 
did not contain records on the volume used, so this 
refers to the same issue abovementioned, the lack of 
documentation can interfere with preventive measures 
to be adopted.
The vast majority of studies on nephrotoxicity 
related to contrast recommended that all patients should 
receive oral or intravenous hydration, but few of them 
compare the use or non-use of this type of treatment. 
A study that compared three types of preparation, 
normal saline, normal saline and N-acetylcysteine and 
sodium bicarbonate, showed no differences between the 
standard method (saline) and other preparations(23).
Hydration with 0.9% NS for at least 1ml/kg/hour, 
and if possible 100-150ml/h for 12 hours before and 
after the procedure, is one of the most appropriate 
prophylactic measures to prevent alteration of renal 
function after receiving the contrast. Satisfactory 
outcomes with the use of normal saline before elective 
procedures, and even in emergency cases(19), were also 
obtained. Studies such as this show the importance 
of hydration prior to contrast studies, however, in this 
study, only 49.46% of patients received intravenous 
hydration as has been advocated in the literature.
A study showed that N-acetylcysteine associated 
with increased hydration was more effective compared 
to hydration alone. It is known that N-acetylcysteine has 
a vasodilatory property, so it increases the expression 
of the nitric oxide synthase enzyme and may prevent 
contrast-induced nephropathy (CIN) both by reducing 
the direct oxidative damage and by improving 
hemodynamics of the kidney(17). 
A study showed that the N-acetylcysteine dosage 
that should be administered to someone performing 
contrast-enhanced exam should be 600mg orally 
12/12h a day before the exam and 24 hours after the 
procedure. In emergency cases, one must consider the 
use of intravenous n-acetylcysteine 150mg/kg in 500ml 
of normal saline 30 minutes before the procedure and 
50mg/kg four hours after it, as recommended by the 
Rappid trial(24).
Despite advances in studies that show the 
effectiveness of N-acetylcysteine as a protective 
measure of the renal function before and after contrast 
examinations, we did not find the use of this prophylactic 
measure in most patients’ record in the present study. 
Only 15.05% of patients received N-acetylcysteine 
before the procedure and 7.52 % used the solution after 
the exam with contrast media.
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One study demonstrated that the combination 
of medications and hydration provided better renal 
protection against contrast induced injury than hydration 
alone, in patients with prior renal damage. Although 
these authors believed in the beneficial union between 
N-acetylcysteine and hydration, other conflicting results 
were found in the literature, which might be explained 
by the differences among the study population and/
or in the diversity of N-acetylcysteine administration 
protocols. Moreover, one needs to consider findings 
claiming that N-acetylcysteine may interfere with the 
tubular transport of creatinine, leading to a decrease in 
its serum levels(13).
A study compared the concentrations of creatinine 
and cystatin C, four hours before and 48 hours after 
oral administration of N-acetylcysteine (600mg, four 
doses every 12 hours) in 50 volunteers with normal 
renal function receiving no radiocontrast. There was a 
significant decrease in mean serum creatinine, while the 
cystatin C, which is a marker of renal function that is 
not affected by tubular transport, showed no change(13). 
According to most studies, the lack of preventive 
measures for the performance of contrast examination 
provides alteration of renal function that can be of pre-
renal origin, due to lack of blood perfusion, since in 
principle the contrast causes vasodilatation followed by 
a vasoconstriction. The change in renal function should 
be diagnosed early because it is reversible, but, if left 
untreated, it can cause acute tubular necrosis (ATN) and 
consequently AKI(5).
In this study, the control of serum creatinine before 
and after the contrast examination was observed in only 
49.5% of patients, and among the values it was possible 
to detect a statistically significant increase in creatinine 
after the use of contrast with a p-value of 0.04. We 
could not analyze all of the individuals in relation to the 
dosage of creatinine prior to and post-exam, as some 
had only pre-scan creatinine values and others only 
post-scan creatinine measures. Among patients who 
had the determination of creatinine before and after 
the examination, only 22.6% received some type of 
prophylactic measure against impaired renal function.
The fact that an individual has underlying disease 
is not the only aggravating factor for the occurrence 
of renal disorders. The elderly are more likely to 
exhibit risk for contrast-induced nephropathy factors, 
and among these, patients with chronic renal failure 
undergoing conservative treatment and patients with 
diabetes mellitus are serious candidates(25). Other 
studies have shown that there is an increasing use 
of contrast media to perform procedures in elderly 
people, information compatible with the sample of the 
current study that evaluated individuals >60 years of 
age. On the other hand, the impact of age as a negative 
prognostic factor in patients who experience renal 
disorder is not clear, and there is a tendency in the 
literature not to consider age as a negative factor in the 
evolution of these patients(18).
The alterations in the kidney hemodynamics can 
collaborate, to some degree, with the renal dysfunction, 
so that some theories are based on the assumption that 
the aging process of kidney, the higher frequency of 
pathological conditions in the elderly, the excessive use 
of medications by elderly patients, and the increased 
frequency of interventional and surgical procedures 
are factors that increase the chances of an individual 
for developing any change in renal function(18). The 
increase in creatinine values, as claimed by some 
studies(6), occured within 48 hours; other authors(13) 
emphasized that this increase may occur 48-72 hours 
after the patient received the contrast. Our results 
show that in 25.8 % of hospitalized patients who had a 
CT scan, the creatinine values was not collected prior to 
the injection of contrast; in 45.2 % of the participants, 
the serum creatinine was not checked after the 
administration of contrast – even with the scientific 
evidence of risks experienced by patients undergoing 
contrast examinations.
The limitations of the study highlight that, despite 
the implemented protocol in the institution on the 
performance of contrast-enhanced CT scan, neither is this 
protocol fulfilled nor are there routines for documenting 
data related to such contrast examinations. 
We considered the conduct of further prospective 
studies in the institution of fundamental importance, so 
that it can implement effective protocols for prevention 
of renal impairment in elderly patients who undergo 
contrast-enhanced examinations, avoiding the risk of 
progression to chronicity.
Conclusions
The current study showed that many elderly had 
contrast-enhanced examination; however, the protocol 
on possible preventive measures of renal dysfunction 
that was implemented in the institution was still not 
being completed. Despite hospitalization, we did not 
find clear documentation about the preventive measures 
that should be used before and after the performance of 
contrast examinations in this age group. 
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The lack of appropriate documentation in some 
cases in regard to the type and volume of contrast used 
in these patients was a limitation of the study. There 
is an urgent need for protocols related to prophylactic 
measures prior to and post contrast-enhanced 
examinations in the elderly, as well as more prospective 
studies to define the prognosis of elderly patients with 
contrast-induced acute renal disorders.
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